Dominant myelopoietic effector functions mediated by chemokine receptor CCR1

Journal of Experimental Medicine

Volumn 189, Issue 12, 1999, Pages 1987-1992

  Broxmeyer, Hal E ^a,b   Cooper, Scott ^a,b   Hangoc, Giao ^a,b   Gao, Ji Liang ^c   Murphy, Philip M ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTHER CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

CC chemokine receptor 1; Macrophage inflammatory protein l ; Mobilization; Progenitor cells; Proliferation

Indexed keywords

CHEMOKINE RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE DISRUPTION; HUMAN TISSUE; MOUSE; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE;

ANIMALS; CELL DIVISION; CHEMOKINES; COLONY-FORMING UNITS ASSAY; ERYTHROID PROGENITOR CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LEUKOPOIESIS; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, KNOCKOUT; RECEPTORS, CHEMOKINE; STEM CELLS;

EID: 0033591690     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.12.1987     Document Type: Article

References (27)

1. Broxmeyer, H.E. 1998. The hematopoietic system: principles of therapy with hematopoietically active cytokines. In Cytokines in the Treatment of Hematopoietic Failure. A. Ganser and D. Hoelzer, editors. Marcel Dekker, Inc., New York. 1-37.
2. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature. 392:565-568.
3. Murphy, P.M. 1996. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev. 7:47-64.
4. Rollins, B.J. 1997. Chemokines. Blood. 90:909-928.
5. Broxmeyer, H.E., and C.H. Kim. 1999. Chemokines and hematopoiesis. In Chemokines and Cancer. B.J. Rollins, editor. Humana Press, Inc., Totowa, NJ. 263-291.
6. Broxmeyer, H.E., B. Sherry, L. Lu, S. Cooper, C. Carow, S.D. Wolpe, and A. Cerami. 1989. Myelopoietic enhancing effects of murine macrophage inflammatory proteins 1 and 2 in vitro on colony formation by murine and human bone marrow granulocyte-macrophage progenitor cells. J. Exp. Med. 170:1583-1594.
7. Broxmeyer, H.E., B. Sherry, L. Lu, S. Cooper, K.-O. Oh, P. Tekamp-Olson, B.S. Kwon, and A. Cerami. 1990. Enhancing and suppressing effects of recombinant murine macro-phage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood. 76:1110-1116.
8. Clements, J.M., S. Craig, A.J.H. Gearing, M.G. Hunter, C.M. Heyworth, T.M. Dexter, and B.I. Lord. 1992. Biological and structural properties of MIP-1α expressed in yeast. Cytokine. 4:76-82.
9. Keller, J.R., S.H. Bartelmez, E. Sitnicka, F.W. Ruscetti, M. Ortiz, J.M. Gooya, and S.E.W. Jacobson. 1994. Distinct and overlapping direct effects of macrophage inflammatory protein-1α and transforming growth factor β on hematopoietic progenitor/stem cell growth. Blood. 84:2175-2181.
10. + human hematopoietic progenitors. Exp. Hematol. 24:1509-1515.
11. Graham, G.J., E.G. Wright, R. Hewick, S.D. Wolpe, N.M. Wilkie, D. Donaldson, S. Lorimore, and I.B. Pragnell. 1990. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature. 344:442-444.
12. Broxmeyer, H.E., B. Sherry, S. Cooper, L. Lu, R. Maze, M.P. Beckmann, A. Cerami, and P. Ralph. 1993. Comparative analysis of the suppressive effects of the human macro-phage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. J. Immunol. 150:3448-3458.
13. +++ stem/progenitor cells from human bone marrow and umbilical cord blood plated with and without serum. Exp. Hematol. 21: 1442-1446.
14. Dunlop, D.J., E.G. Wright, S. Lorimore, G.J. Graham, T. Holyoake, D.J. Kerr, S.D. Wolpe, and I.B. Pragnell. 1992. Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP-1α in vivo. Blood. 79:2221-2225.
15. Broxmeyer, H.E., A. Orazi, N.L. Hague, G.W. Sledge, Jr., H. Rasmussen, and M.S. Gordon. 1998. Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1α, in a phase I clinical trial in patients with relapsed/refractory breast cancer. Blood Cells Mol. Dis. 24:14-30.
16. Maze, R., B. Sherry, B.S. Kwon, A. Cerami, and H.E. Broxmeyer. 1992. Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1 alpha. J. Immunol. 149:1004-1009.
17. Lord, B.I., T.M. Dexter, J.M. Clements, M.A. Hunter, and A.J.H. Gearing. 1992. Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. Blood. 79:2605-2609.
18. Lord, B.I., L.B. Woolford, L.M. Wood, L.G. Czaplewski, M. McCourt, M.G. Hunter, and R.M. Edwards. 1995. Mobilization of early hematopoietic progenitor cells with BB10010: a genetically engineered variant of human macrophage inflammatory protein-1α. Blood. 85:3412-3415.
19. Nibbs, R.J., S.M. Wylie, J. Yang, N.R. Landau, and G.J. Graham. 1997. Cloning and characterization of a novel promiscuous human beta chemokine receptor D6. J. Biol. Chem. 272:32078-32083.
20. Gao, J.L., T.A. Wynn, Y. Chang, E. Lee, H.E. Broxmeyer, E. Cooper, H.L. Tiffany, H. Westphal, J. Kwon-Chung, and P.M. Murphy. 1997. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185:1959-1968.
21. Hromas, R., P.W. Gray, D. Chantry, M. Krathwohl, K. Fife, G.I. Bell, J. Takeda, S. Aronica, M. Gordon, S. Cooper, et al. 1997. Cloning and characterization of exodus, a novel β-chemokine. Blood. 89:3315-3322.
22. Cooper, S., and H.E. Broxmeyer. 1996. Measurement of interleukin-3 and other hematopoietic growth factors, such as GM-CSF, G-CSF, M-CSF, erythropoietin and the potent co-stimulating cytokines steel factor and Flt-3 ligand. In Current Protocols in Immunology, Suppl. 18. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, W. Strober, and R. Coico, editors. John Wiley & Sons, Inc., New York. 6.4.1-6.4.12.
23. Su, S.B., N. Mukaida, J.B. Wang, Y. Zhang, A. Takami, S. Nakao, and K. Matsushima. 1997. Inhibition of immature erythroid progenitor cell proliferations by macrophage inflammatory protein-1α by interacting mainly with a C-C chemokine receptor, CCR1. Blood. 90:605-611.
24. Liu, F., J. Poursine-Laurent, and D.C. Link. 1997. The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not Flt-3 ligand. Blood. 90:2522-2528.
25. Boring, L., J. Gosling, S.W. Chensue, S.L. Kunkel, R.V. Farese, Jr., H.E. Broxmeyer, and I.F. Charo. 1997. Impaired monocyte migration and reduced type 1 (ThI) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100:2552-2561.
26. Reid, S., A. Ritchie, L. Boring, S. Cooper, G. Hangoc, I.F. Charo, and H.E. Broxmeyer. 1999. Enhanced myeloid progenitor cell cycling and apoptosis in mice lacking the chemokine receptor, CCR2. Blood. 93:1524-1533.
27. Broxmeyer, H.E., S. Cooper, G. Cacalano, N.L. Hague, E. Bailish, and M.W. Moore. 1996. Interleukin-8 receptor is involved in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homolog. J. Exp. Med. 184:1825-1832.